甘精胰岛素的全科门诊应用(2)
 |
| 第1页 |
参见附件。
5 2010年版中国2型糖尿病防治指南.
6 Riddle MC，et al.Diabetes Care published online October 25，2011.
7 Lawes CM，Parag V，Bennett DA，et al.Blood glucose and risk of cardiovascular disease in the Asia Pacific region.Diabetes Care.2004；27：2836-2842.
8 Nazimek-Siewniak B，Moczulski D，Grzeszczak W.Risk of macrovascular and microvascular complications in Type 2 diabetes：results of longitudinal study design.J Diabetes Complications.2002，18：271-276.
9 Pang Can，Bao YQ，Wang C，et al.Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes.Chin Med J，2008，121：2119-2123.
10 John D，Robertson RP，Lerner RL，et al.Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests.J Clin Endocrinol Metab 1976，42：222-229.
11 Pennartz C，Schenker N，Menge BA，et al.Chronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetes.Diabetes Care，2011，34：2048-2053.
12 Zeng LY，et al.Diabetes Technol &Ther DOI：10.1089/dia.2011，1：23.
您现在查看是摘要介绍页，详见PDF附件。